ATCvet code QJ51

Last updated
ATC codes
J Antiinfectives for systemic use
J01 Antibacterials for systemic use
J02 Antimycotics for systemic use
J04 Antimycobacterials
J05 Antivirals for systemic use
Human only
J06 Immune sera and immunoglobulins
J07 Vaccines
ATCvet only
QJ51 Antibacterials for intramammary use
QJ54 Antimycobacterials for intramammary use

ATCvet code QJ51Antibacterials for intramammary use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System for veterinary medicinal products, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical productsfor veterinary use. [1] [2] Subgroup QJ51 is part of the anatomical group QJ Antiinfectives for systemic use. [3]

Contents

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

QJ51A Tetracyclines for intramammary use

QJ51AA Tetracyclines

QJ51AA03 Chlortetracycline
QJ51AA06 Oxytetracycline
QJ51AA07 Tetracycline
QJ51AA53 Chlortetracycline, combinations

QJ51B Amphenicols for intramammary use

QJ51BA Amphenicols

QJ51BA01 Chloramphenicol
QJ51BA02 Thiamphenicol
QJ51BA90 Florfenicol

QJ51C Beta-lactam antibacterials, penicillins, for intramammary use

QJ51CA Penicillins with extended spectrum

QJ51CA01 Ampicillin
QJ51CA51 Ampicillin, combinations

QJ51CE Beta-lactamase sensitive penicillins

QJ51CE01 Benzylpenicillin
QJ51CE09 Procaine penicillin
QJ51CE59 Procaine penicillin, combinations
QJ51CE90 Phenetamate

QJ51CF Beta-lactamase resistant penicillins

QJ51CF01 Dicloxacillin
QJ51CF02 Cloxacillin
QJ51CF03 Meticillin
QJ51CF04 Oxacillin
QJ51CF05 Flucloxacillin

QJ51CR Combinations of pencillins and/or beta-lactamase inhibitors

QJ51CR01 Ampicillin and enzyme inhibitor
QJ51CR02 Amoxicillin and enzyme inhibitor
QJ51CR50 Combinations of penicillins

QJ51D Other beta-lactam antibacterials for intramammary use

QJ51DB First-generation cephalosporins

QJ51DB01 Cefalexin
QJ51DB04 Cefazolin
QJ51DB08 Cefapirin
QJ51DB10 Cefacetrile
QJ51DB90 Cefalonium

QJ51DC Second-generation cephalosporins

QJ51DC02 Cefuroxime

QJ51DD Third-generation cephalosporins

QJ51DD12 Cefoperazone
QJ51DD90 Ceftiofur

QJ51DE Fourth-generation cephalosporins

QJ51DE90 Cefquinome

QJ51E sulfonamides and trimethoprim for intramammary use

QJ51EA Trimethoprim and derivatives

QJ51EA01 Trimethoprim

QJ51F Macrolides and lincosamides for intramammary use

QJ51FA Macrolides

QJ51FA01 Erythromycin
QJ51FA02 Spiramycin
QJ51FA90 Tylosin

QJ51FF Lincosamides

QJ51FF90 Pirlimycin
QJ51FF02 Lincomycin

QJ51G Aminoglycoside antibacterials for intramammary use

QJ51GA Streptomycins

QJ51GA90 Dihydrostreptomycin

QJ51GB Other aminoglycosides

QJ51GB03 Gentamicin
QJ51GB90 Apramycin

QJ51R Combination of antibacterials for intramammary use

QJ51RA Tetracyclines, combinations with other antibacterials

QJ51RA01 Chlortetracycline, combinations with other antibacterials

QJ51RB Amphenicols, combinations with other antibacterials

QJ51RB01 Chloramphenicol, combinations with other antibacterials

QJ51RC Beta-lactam antibacterials, penicillins, combinations with other antibacterials

QJ51RC04 Procaine penicillin, dihydrostreptomycin, sulfadimidin
QJ51RC20 Ampicillin, combinations with other antibacterials
QJ51RC21 Pivampicillin, combinations with other antibacterials
QJ51RC22 Benzylpenicillin, combinations with other antibacterials
QJ51RC23 Procaine penicillin, combinations with other antibacterials
QJ51RC24 Benzathine benzylpenicillin, combinations with other antibacterials
QJ51RC25 Penethamate hydroiodide, combinations with other antibacterials
QJ51RC26 Cloxacillin, combinations with other antibacterials

QJ51RD Other beta-lactam antibacterials, combinations with other antibacterials

QJ51RD01 Cefalexin, combinations with other antibacterials
QJ51RD34 Cefacetrile, combinations with other antibacterials

QJ51RE Sulfonamides and trimethoprim including derivatives

QJ51RE01 Sulfadiazine and trimethoprim

QJ51RF Macrolides and lincosamides, combinations with other antibacterials

QJ51RF01 Spiramycin, combinations with other antibacterials
QJ51RF02 Erythromycin, combinations with other antibacterials
QJ51RF03 Lincomycin, combinations with other antibacterials

QJ51RG Aminoglycoside antibacterials, combinations

QJ51RG01 Neomycin, combinations with other antibacterials

QJ51RV Combinations of antibacterials and other substances

QJ51RV01 Antibacterials and corticosteroids
QJ51RV02 Antibacterials, antimycotics and corticosteroids

QJ51X Other antibacterials for intramammary use

QJ51XB Polymyxins

QJ51XB01 Colistin
QJ51XB02 Polymyxin B

QJ51XX Other antibacterials for intramammary use

QJ51XX01 Rifaximin

Related Research Articles

This is the timeline of modern antimicrobial (anti-infective) therapy. The years show when a given drug was released onto the pharmaceutical market. This is not a timeline of the development of the antibiotics themselves.

ATC code A01Stomatological preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup A01 is part of the anatomical group A Alimentary tract and metabolism.

ATC code A07Antidiarrheals, intestinal anti-inflammatory/anti-infective agents is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup A07 is part of the anatomical group A Alimentary tract and metabolism.

ATC code A12Mineral supplements is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup A12 is part of the anatomical group A Alimentary tract and metabolism.

ATC code C01Cardiac therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup C01 is part of the anatomical group C Cardiovascular system.

ATC code C02Antihypertensives is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup C02 is part of the anatomical group C Cardiovascular system.

ATC code C05Vasoprotectives is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup C05 is part of the anatomical group C Cardiovascular system.

ATC code D06Antibiotics and chemotherapeutics for dermatological use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup D06 is part of the anatomical group D Dermatologicals.

ATC code D10Anti-acne preparations is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup D10 is part of the anatomical group D Dermatologicals.

ATC code G03Sex hormones and modulators of the genital system is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup G03 is part of the anatomical group G Genito-urinary system and sex hormones.

ATC code J01Antibacterials for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup J01 is part of the anatomical group J Antiinfectives for systemic use.

ATC code J04Antimycobacterials is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup J04 is part of the anatomical group J Antiinfectives for systemic use.

ATC code N01Anesthetics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup N01 is part of the anatomical group N Nervous system.

ATC code N05Psycholeptics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup N05 is part of the anatomical group N Nervous system.

ATC code S01Ophthalmologicals is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup S01 is part of the anatomical group S Sensory organs.

ATC code S02Otologicals is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Subgroup S02 is part of the anatomical group S Sensory organs.

Flucloxacillin

Flucloxacillin, also known as floxacillin, is an antibiotic used to treat skin infections, external ear infections, infections of leg ulcers, diabetic foot infections, and infection of bone. It may be used together with other medications to treat pneumonia, and endocarditis. It may also be used prior to surgery to prevent Staphylococcus infections. It is not effective against methicillin-resistant Staphylococcus aureus (MRSA). It is taken by mouth or given by injection into a vein or muscle.

ATCvet code QG51Antiinfectives and antiseptics for intrauterine use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System for veterinary medicinal products, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products for veterinary use. Subgroup QG51 is part of the anatomical group QG Genito-urinary system and sex hormones.

References

  1. "The ATCvet classification system" (PDF). European Medicines Agency . Retrieved 2020-02-01.
  2. "ATCvet Code, ein Klassierungssystem für Tierarzneimittel" (in German). University of Zurich . Retrieved 2020-02-01.
  3. "ATCvet Index 2021: code QJ51". WHO Collaborating Centre for Drug Statistics Methodology.